• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
miRNA nanotherapeutics: potential and challenges in respiratory disorders.微小RNA纳米疗法：呼吸系统疾病中的潜力与挑战
Future Med Chem. 2020 Jun;12(11):987-990. doi: 10.4155/fmc-2020-0066. Epub 2020 Apr 9.
2
Targeting respiratory diseases using miRNA inhibitor based nanotherapeutics: Current status and future perspectives.利用 miRNA 抑制剂的纳米治疗方法靶向治疗呼吸疾病：现状与未来展望。
Nanomedicine. 2021 Jan;31:102303. doi: 10.1016/j.nano.2020.102303. Epub 2020 Sep 24.
3
Can nanotechnology hit the spot in aerosol-based drug delivery for lung disorders?纳米技术能在基于气雾剂的肺部疾病药物递送中发挥作用吗？
Ther Deliv. 2018 Mar 1;9(4):233-236. doi: 10.4155/tde-2017-0112. Epub 2018 Mar 2.
4
Targeting microRNAs using nanotechnology in pulmonary diseases.利用纳米技术靶向微小RNA治疗肺部疾病
Panminerva Med. 2018 Dec;60(4):230-231. doi: 10.23736/S0031-0808.18.03459-6.
5
miRNA nanotherapeutics for cancer.用于癌症治疗的微小RNA纳米疗法
Drug Discov Today. 2017 Feb;22(2):424-432. doi: 10.1016/j.drudis.2016.10.014. Epub 2016 Nov 1.
6
Systemic Delivery of Anti-miRNA for Suppression of Triple Negative Breast Cancer Utilizing RNA Nanotechnology.利用RNA纳米技术进行抗miRNA的全身递送以抑制三阴性乳腺癌
ACS Nano. 2015 Oct 27;9(10):9731-40. doi: 10.1021/acsnano.5b02471. Epub 2015 Sep 21.
7
Promises of Nanotherapeutics in Obesity.纳米疗法在肥胖症中的应用前景。
Trends Endocrinol Metab. 2019 Jun;30(6):369-383. doi: 10.1016/j.tem.2019.04.004. Epub 2019 May 21.
8
Nanotechnology approaches for inhalation treatment of lung diseases.纳米技术在肺部疾病吸入治疗中的应用。
J Control Release. 2015 Dec 10;219:500-518. doi: 10.1016/j.jconrel.2015.07.024. Epub 2015 Aug 19.
9
Interleukin-17A: A Potential Therapeutic Target in Chronic Lung Diseases.白细胞介素-17A：慢性肺部疾病的潜在治疗靶点。
Endocr Metab Immune Disord Drug Targets. 2019;19(7):921-928. doi: 10.2174/1871530319666190116115226.
10
Reflections on microRNAs in chronic pulmonary disease: looking into the miR-ror and crystal ball.慢性肺部疾病中微小RNA的思考：透过“镜子”与“水晶球”洞察
Inflamm Allergy Drug Targets. 2013 Apr;12(2):88-98. doi: 10.2174/1871528111312020003.

引用本文的文献

1
Potential MiRNA therapies for premature ovarian failure: new challenges and opportunities.针对卵巢早衰的潜在微小RNA疗法：新挑战与新机遇
Stem Cell Res Ther. 2025 Jul 15;16(1):364. doi: 10.1186/s13287-025-04514-z.
2
MicroRNAs as promising drug delivery target to ameliorate chronic obstructive pulmonary disease using nano-carriers: a comprehensive review.利用纳米载体将微小RNA作为改善慢性阻塞性肺疾病的有前景的药物递送靶点：综述
Mol Cell Biochem. 2025 Mar;480(3):1431-1448. doi: 10.1007/s11010-024-05110-0. Epub 2024 Sep 10.
3
Aerosol pulmonary immune engineering.气溶胶肺部免疫工程。
Adv Drug Deliv Rev. 2023 Aug;199:114831. doi: 10.1016/j.addr.2023.114831. Epub 2023 Apr 24.
4
Targeting Inflammasome Activation in COVID-19: Delivery of RNA Interference-Based Therapeutic Molecules.靶向新冠病毒感染中的炎性小体激活：基于RNA干扰的治疗性分子递送
Biomedicines. 2021 Dec 3;9(12):1823. doi: 10.3390/biomedicines9121823.
5
Inhaled RNA Therapeutics for Obstructive Airway Diseases: Recent Advances and Future Prospects.用于阻塞性气道疾病的吸入式RNA疗法：最新进展与未来前景
Pharmaceutics. 2021 Jan 28;13(2):177. doi: 10.3390/pharmaceutics13020177.
6
Interferon therapy for preventing COPD exacerbations.用于预防慢性阻塞性肺疾病加重的干扰素疗法。
EXCLI J. 2020 Nov 4;19:1477-1480. doi: 10.17179/excli2020-2997. eCollection 2020.
7
Emerging concepts and directed therapeutics for the management of asthma: regulating the regulators.哮喘管理的新观念和靶向治疗：调控调控因子。
Inflammopharmacology. 2021 Feb;29(1):15-33. doi: 10.1007/s10787-020-00770-y. Epub 2020 Nov 5.

本文引用的文献

1
Folic acid (FA)-conjugated mesoporous silica nanoparticles combined with MRP-1 siRNA improves the suppressive effects of myricetin on non-small cell lung cancer (NSCLC).叶酸（FA）偶联介孔硅纳米颗粒联合 MRP-1 siRNA 增强杨梅素对非小细胞肺癌（NSCLC）的抑制作用。
Biomed Pharmacother. 2020 May;125:109561. doi: 10.1016/j.biopha.2019.109561. Epub 2020 Feb 25.
2
Coated cationic lipid-nanoparticles entrapping miR-660 inhibit tumor growth in patient-derived xenografts lung cancer models.包被阳离子脂质纳米颗粒包载 miR-660 抑制患者来源异种移植肺癌模型中的肿瘤生长。
J Control Release. 2019 Aug 28;308:44-56. doi: 10.1016/j.jconrel.2019.07.006. Epub 2019 Jul 9.
3
Identification of biomarkers and genetic approaches toward chronic obstructive pulmonary disease.慢性阻塞性肺疾病的生物标志物鉴定和遗传方法。
J Cell Physiol. 2019 Aug;234(10):16703-16723. doi: 10.1002/jcp.28482. Epub 2019 Mar 25.
4
The Global Burden of Pulmonary Diseases: Most Prevalent Problems and Opportunities for Improvement.《全球肺部疾病负担：最普遍的问题和改进机会》。
Ann Glob Health. 2019 Jan 22;85(1):1. doi: 10.5334/aogh.2411.
5
Polymeric nanoparticles for the delivery of miRNA to treat Chronic Obstructive Pulmonary Disease (COPD).聚合物纳米粒用于递送 miRNA 治疗慢性阻塞性肺疾病 (COPD)。
Eur J Pharm Biopharm. 2019 Mar;136:1-8. doi: 10.1016/j.ejpb.2019.01.002. Epub 2019 Jan 4.
6
Targeting microRNAs using nanotechnology in pulmonary diseases.利用纳米技术靶向微小RNA治疗肺部疾病
Panminerva Med. 2018 Dec;60(4):230-231. doi: 10.23736/S0031-0808.18.03459-6.
7
Multi-drug resistant Mycobacterium tuberculosis & oxidative stress complexity: Emerging need for novel drug delivery approaches.耐多药结核分枝杆菌与氧化应激复杂性：新型药物输送方法的新需求。
Biomed Pharmacother. 2018 Nov;107:1218-1229. doi: 10.1016/j.biopha.2018.08.101. Epub 2018 Aug 29.
8
Nanoparticle-antagomiR based targeting of miR-31 to induce osterix and osteocalcin expression in mesenchymal stem cells.基于纳米颗粒抗微小RNA的miR-31靶向作用以诱导间充质干细胞中osterix和骨钙素的表达
PLoS One. 2018 Feb 14;13(2):e0192562. doi: 10.1371/journal.pone.0192562. eCollection 2018.
9
Therapeutic prospects of microRNAs in cancer treatment through nanotechnology.通过纳米技术治疗癌症的 microRNAs 的治疗前景。
Drug Deliv Transl Res. 2018 Feb;8(1):97-110. doi: 10.1007/s13346-017-0440-1.
10
Recent Advances in Nanomaterials for Gene Delivery-A Review.用于基因递送的纳米材料的最新进展——综述
Nanomaterials (Basel). 2017 Apr 28;7(5):94. doi: 10.3390/nano7050094.

miRNA nanotherapeutics: potential and challenges in respiratory disorders.

作者信息

Mehta Meenu, Chellappan Dinesh K, Wich Peter R, Hansbro Nicole G, Hansbro Philip M, Dua Kamal

机构信息

Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, NSW, 2007, Australia.

Centre for Inflammation, Centenary Institute, Sydney, NSW, 2050, Australia.

出版信息

Future Med Chem. 2020 Jun;12(11):987-990. doi: 10.4155/fmc-2020-0066. Epub 2020 Apr 9.

DOI:10.4155/fmc-2020-0066
PMID:32270706
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7351087/
Abstract
摘要